Skip to content Semaglutide is a GLP-1 receptor agonist that a licensed provider may consider as part of a medically supervised weight-management plan. At Remedy in Maple Grove, MN, it’s never a one-click purchase — care begins with labs and a clinical evaluation to determine whether it’s appropriate for you.
Semaglutide is the active ingredient in several FDA-approved medications, available as a weekly injection or a daily oral tablet depending on the product and your provider’s recommendation. It is FDA approved for chronic weight management in adults who meet specific clinical criteria, and under other brand names for type 2 diabetes. Whether it’s appropriate for you is a clinical decision made after your evaluation.
Your provider reviews bloodwork before recommending treatment.
If appropriate, dosing is tailored and adjusted under supervision.
Follow-up visits track tolerability and response.
Your provider explains benefits, risks, and alternatives before you start.
Prescribed only within a legitimate provider–patient relationship.
Medication is one part of a broader, personalized plan.
After labs and a consultation, your provider determines whether semaglutide is clinically appropriate. If so, they explain the dosing schedule, what to expect, and how you’ll be monitored. Your plan is reviewed at follow-ups and adjusted based on your response and tolerability.
Review of your history, medications, and goals, plus bloodwork.
Your provider assesses eligibility and discusses whether semaglutide fits your plan.
If appropriate, your provider prescribes and explains dosing and monitoring.
Regular check-ins to assess response and adjust safely.
Are an adult pursuing medically supervised weight management.
Are willing to complete lab work and attend follow-ups.
Prefer licensed oversight over prescription-free online products.
Have realistic expectations and are in general health.
Eligibility is determined by your provider.
Semaglutide is prescribed only pursuant to a valid prescription after a legitimate provider–patient relationship. Common considerations, including gastrointestinal effects, are reviewed during informed consent. We do not sell medication as a retail product and do not guarantee outcomes. Pricing is provided upfront.
That depends on your provider’s recommendation and your evaluation. Both forms exist; your provider will discuss which is appropriate.
No. An evaluation is required before any prescription.
Your provider will review possible effects, including gastrointestinal symptoms, during informed consent.
We prescribe FDA-approved medication. Compounded forms are used only in the narrow circumstances current FDA policy allows.
